Quantitative genetic variations and essential hypertension.
Smithies
O
O
Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D009320:Atrial Natriuretic Factor / Q000502:physiology; D001794:Blood Pressure / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D003198:Computer Simulation; D018628:Gene Dosage; D018390:Gene Targeting; D014644:Genetic Variation; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000235:genetics* / Q000503:physiopathology; D051379:Mice; D008957:Models, Genetic; D020097:Natriuretic Peptide, Brain / Q000502:physiology; D012084:Renin-Angiotensin System / Q000235:genetics / Q000502:physiology
D000806:Angiotensin-Converting Enzyme Inhibitors; D020097:Natriuretic Peptide, Brain; D009320:Atrial Natriuretic Factor